Cian Healthcare Limited (BOM:542678)

Market Cap	104.98M
Revenue (ttm)	481.76M
Net Income (ttm)	-165.19M
Shares Out	25.00M
EPS (ttm)	-6.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,000
Average Volume	67,700
Open	4.200
Previous Close	4.210
Day's Range	4.200 - 4.250
52-Week Range	2.970 - 26.200
Beta	-0.28
RSI	63.20
Earnings Date	Aug 14, 2025

About Cian Healthcare

Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of orthopedics, gynecology, pediatrics, cardiac, diabetic, derma-cosmetic, pain management, antibiotics, central nervous system, neuro, critical care, gastro-intestinal, and vitamins and nutrient products. The company also provides male and female infertility, energy and immunity boosting, protein supplement, arthritis and joint pain, hepatoprotective, ...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 257
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 542678

Financial Performance

In 2023, Cian Healthcare's revenue was 618.92 million, a decrease of -9.88% compared to the previous year's 686.76 million. Earnings were 2.54 million, a decrease of -87.47%.